Panchsheel Organics Limited

PANCHSHEEL

INE316G01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:00:56 31/05/2024 BST			5-day change	1st Jan Change
191.3 ^INR	+0.03%		-3.80%	-2.40%

05-29	Panchsheel Organics Limited Recommends Final Dividend	CI
05-21	Panchsheel Organics Limited Appoints Sonia Verma as Company Secretary and Compliance Officer	CI

Panchsheel Organics Limited Appoints Amit Jain as Company Secretary and Compliance Officer

December 24, 2019 at 01:55 pm

Panchsheel Organics Limited announced the appointment of Mr. Amit Jain as the Company Secretary and Compliance Officer of the company with effect from December 24, 2019.

Latest news about Panchsheel Organics Limited

Panchsheel Organics Limited Recommends Final Dividend	05-29	CI
Panchsheel Organics Limited Appoints Sonia Verma as Company Secretary and Compliance Officer	05-21	CI
Panchsheel Organics Limited Announces Resignation of Hitesh Singh Parihar as Company Secretary & Compliance Officer	03-29	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year 2023-24, Payable on or Before March 13, 2024	02-14	CI
Panchsheel Organics Names CFO	02-14	MT
Panchsheel Organics Limited Announces CFO Changes	02-13	CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-13	CI
Panchscheel Organics Board Declares Interim Dividend for Fiscal 2024	11-21	MT
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-10	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 10, 2023	11-10	CI
Panchsheel Organics Limited Approves Dividend	16/08/23	CI
Panchsheel Organics Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Panchsheel Organics Limited Recommends Final Dividend for the Financial Year 2022-23	30/05/23	CI
Panchsheel Organics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	30/05/23	CI
Panchsheel Organics Limited Announces the Appointment of Hitesh Singh Parihar as Company Secretary and Compliance Officer	29/04/23	CI
Panchsheel Organics Limited Announces the Appointment of Gaurang Natavar Patel as Chief Financial Officer	29/04/23	CI
Panchsheel Organics Limited Announces Demise of Chandrakant Shah, Chief Financial Officer	10/04/23	CI
Panchsheel Organics Limited Declares Interim Dividend for the Year Ending March 31, 2023, Payable on or Before March 14, 2023	13/02/23	CI
Panchsheel Organics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23	CI
Panchsheel Organics Limited Announces Resignation of Nikhil Borana as Company Secretary & Compliance Officer	04/02/23	CI
Panchsheel Organics Secures Land for Fermentation Facility in Indore, India	23/11/22	MT
Panchsheel Organics Limited Receives Allotment of Land in DMIC Vikram Udyogpuri Biotech Park Near Indore	23/11/22	CI
Panchsheel Organics Limited Declares Interim Dividend for the Financial Year Ending on March 31, 2023, Payable on or Before December 14, 2022	14/11/22	CI
Panchsheel Organics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22	CI
Panchsheel Organics Limited announced that it has received INR 388.909868 million in funding from a group of investors	07/09/22	CI

Chart Panchsheel Organics Limited

Duration

Period

More charts

Panchsheel Organics Limited is an India-based company engaged in manufacturing and exporting active pharmaceutical ingredients (APIs), intermediates and finished formulations (both human and veterinary). Its specialties include steroids and hormones, veterinary products, over-the-counter products, oncology products, nutraceutical products, micro pellets and direct compression granules, fitness and healthcare, and product development and testing laboratory. The Company offers a range of products under categories, such as cardiovascular, neuropsychiatry, anti-fungal, fluoroquinolones, antiallergic, anti-inflammatory, gastrointestinal, osteoporosis and erectile dysfunction, among others. Its API product range includes Acamprosate Calcium, Amiodarone, Leflunomide, and others. Its hormones and steroids product range includes Cyproterone Acetate, Desogestrel and others. Its nutraceuticals and healthcare products include Alpha Linolenic Acid (ALA) Powder, Phytosterol, and others.

Sector

Pharmaceuticals

Calendar

07/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PANCHSHEEL ORGANICS LIMITED	-2.40%	30.19M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B